Auxilium Pharmaceuticals Inc (NASDAQ:AUXL)

CAPS Rating: 3 out of 5

A specialty biopharmaceutical company with a focus on developing and marketing products to urologists, endocrinologists, orthopedists and select primary care physicians.

Recs

2
Player Avatar zzlangerhans (99.84) Submitted: 5/27/2010 10:22:42 PM : Outperform Start Price: $28.99 AUXL Score: -71.79

Auxilium has been selling off lately likely due to pessimism about the launch of Xiaflex. Do I have an inside track on the issues of usage and reimbursement? Unfortunately not. But I don't believe the drop in share price indicates that anyone else does either. With Testim revenues still increasing and the jury still out on Xiaflex I believe the risk/reward profile has swung towards green.

Featured Broker Partners


Advertisement